MENU
+Compare
ONC
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$368.40
Change
-$9.07 (-2.40%)
Capitalization
40.94B

ONC BeOne Medicines Ltd Forecast, Technical & Fundamental Analysis

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales... Show more

Industry: #Biotechnology
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ONC with price predictions
Nov 12, 2025

Momentum Indicator for ONC turns positive, indicating new upward trend

ONC saw its Momentum Indicator move above the 0 level on November 05, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ONC just turned positive on November 05, 2025. Looking at past instances where ONC's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

ONC moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ONC advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for ONC crossed bearishly below the 50-day moving average on October 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ONC broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ONC entered a downward trend on November 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.111) is normal, around the industry mean (24.439). ONC's P/E Ratio (725.904) is considerably higher than the industry average of (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (8.446) is also within normal values, averaging (322.723).

View a ticker or compare two or three
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ONC is expected to report earnings to fall 52.08% to $1.27 per share on April 01

BeOne Medicines Ltd ONC Stock Earnings Reports
Q4'25
Est.
$1.27
Q3'25
Beat
by $1.85
Q2'25
Missed
by $0.04
Q1'25
Beat
by $1.65
Q4'24
Missed
by $0.42
The last earnings report on November 06 showed earnings per share of $2.65, beating the estimate of 80 cents. With 205.23K shares outstanding, the current market capitalization sits at 40.94B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GRID156.250.68
+0.44%
First Trust NASDAQ® Cln Edge®StGidIfsETF
FPWR34.200.08
+0.22%
First Trust EIP Power Solutions ETF
TIME24.800.02
+0.09%
Clockwise Core Equity & Innovation ETF
CXSE42.04-0.09
-0.21%
WisdomTree China ex-State-Owd Entpr ETF
IGBH24.46-0.11
-0.43%
iShares Interest Rate Hdg L/T Corp BdETF

ONC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+9.84%
ZLAB - ONC
58%
Loosely correlated
-0.55%
MDGL - ONC
42%
Loosely correlated
-2.32%
WXXWY - ONC
37%
Loosely correlated
-0.87%
AXON - ONC
37%
Loosely correlated
-0.47%
GOSS - ONC
35%
Loosely correlated
+4.25%
More